Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Molly M Rajsombath"'
Publikováno v:
EMBO Molecular Medicine, Vol 15, Iss 1, Pp n/a-n/a (2023)
Externí odkaz:
https://doaj.org/article/53108c19caff4a42b16e5f180df29179
Publikováno v:
EMBO Molecular Medicine, Vol 10, Iss 9, Pp 1-17 (2018)
Abstract Environmental enrichment (EE) is a rodent behavioral paradigm that can model the cognitive benefits to humans associated with intellectual activity and exercise. We recently discovered EE's anti‐inflammatory protection of brain microglia a
Externí odkaz:
https://doaj.org/article/6042a47b2d4743dcb10dfa26b12af8bc
Autor:
Xiaoping Hronowski, Haley Cirka, Molly M Rajsombath, Silke Nuber, Kevin J. Hodgetts, Christian P. Müller, Thibaut Imberdis, Andreas Weihofen, Ulf Dettmer, Dennis J. Selkoe, Saranna Fanning, Jürgen Winkler, Alice Y Nam, Liubov S. Kalinichenko, Vera Lambrecht, Junmin Wang
Publikováno v:
Annals of Neurology
Objective Parkinson disease (PD) has useful symptomatic treatments that do not slow the neurodegenerative process, and no significant disease-modifying treatments are approved. A key therapeutic target in PD is α-synuclein (αS), which is both genet
Autor:
Thomas D McCaffery, Silke Nuber, Warren D. Hirst, Alice Y Nam, Tim Moors, Dennis J. Selkoe, Andreas Weihofen, Kelly E. Glajch, Yi Chen, Ulf Dettmer, Molly M Rajsombath, Pascal A Bechade
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America
Significance The mechanisms responsible for brain α-synuclein (αS) dyshomeostasis, caused by Gaucher’s GBA1 mutations that increase Parkinson’s disease (PD) risk, are largely unknown. We previously showed that abrogating physiological αS tetra
Publikováno v:
iScience, Vol 6, Iss, Pp 138-150 (2018)
Summary: Soluble Aβ oligomers (oAβs) contribute importantly to synaptotoxicity in Alzheimer disease (AD), but the mechanisms related to heterogeneity of synaptic functions at local circuits remain elusive. Nearly all studies of the effects of oAβs
Publikováno v:
The Journal of neuroscience : the official journal of the Society for Neuroscience. 39(38)
Many studies report a higher risk for Parkinson's disease (PD) and younger age of onset in men. This, and the fact that the neuropathological process underlying PD symptoms may begin before menopause, suggests that estrogen-based hormone therapy coul
Publikováno v:
EMBO Molecular Medicine
EMBO Molecular Medicine, Vol 10, Iss 9, Pp n/a-n/a (2018)
Xu, H, Rajsombath, M M, Weikop, P & Selkoe, D J 2018, ' Enriched environment enhances β-adrenergic signaling to prevent microglia inflammation by amyloid-β ', EMBO Molecular Medicine, vol. 10, no. 9, e8931 . https://doi.org/10.15252/emmm.201808931
EMBO Molecular Medicine, Vol 10, Iss 9, Pp n/a-n/a (2018)
Xu, H, Rajsombath, M M, Weikop, P & Selkoe, D J 2018, ' Enriched environment enhances β-adrenergic signaling to prevent microglia inflammation by amyloid-β ', EMBO Molecular Medicine, vol. 10, no. 9, e8931 . https://doi.org/10.15252/emmm.201808931
Environmental enrichment (EE) is a rodent behavioral paradigm that can model the cognitive benefits to humans associated with intellectual activity and exercise. We recently discovered EE9s anti‐inflammatory protection of brain microglia against so
Publikováno v:
The Journal of neuroscience : the official journal of the Society for Neuroscience. 36(35)
Microglial dysfunction is increasingly recognized as a key contributor to the pathogenesis of Alzheimer9s disease (AD). Environmental enrichment (EE) is well documented to enhance neuronal form and function, but almost nothing is known about whether
Autor:
Georgia Minakaki, Maria Ericsson, Dennis J. Selkoe, Silke Nuber, Christian P. Müller, Molly M Rajsombath, Ulf Dettmer, Barbara J. Caldarone, Jürgen Winkler
Publikováno v:
Neuron. 100:75-90.e5
Summary α-Synuclein (αS) regulates vesicle exocytosis but forms insoluble deposits in Parkinson’s disease (PD). Developing disease-modifying therapies requires animal models that reproduce cardinal features of PD. We recently described a previous
Autor:
Nuber S; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA., Rajsombath M; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA., Minakaki G; Department of Molecular Neurology, University Hospital Erlangen, Friedrich-Alexander-University (FAU), Erlangen-Nürnberg, 91054 Erlangen, Germany., Winkler J; Department of Molecular Neurology, University Hospital Erlangen, Friedrich-Alexander-University (FAU), Erlangen-Nürnberg, 91054 Erlangen, Germany., Müller CP; Department of Psychiatry and Psychotherapy, Friedrich-Alexander-University (FAU), Erlangen-Nürnberg, 91054 Erlangen, Germany., Ericsson M; Electron Microscopy Laboratory, Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA., Caldarone B; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA; NeuroBehavior Laboratory, Harvard NeuroDiscovery Center, Harvard Medical School, Boston, MA 02115, USA., Dettmer U; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA., Selkoe DJ; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA. Electronic address: dselkoe@bwh.harvard.edu.
Publikováno v:
Neuron [Neuron] 2018 Oct 10; Vol. 100 (1), pp. 75-90.e5.